MSN Laboratories said it has received its clinical trial approval from the DGCI to perform a study on Molnupiravir capsules on mild to moderate Covid patients.from Top India News- News18.com https://ift.tt/3vofFN5
via IFTTT
Tuesday 25 May 2021
MSN Lab Begins Phase III Clinical Trial of Molnupiravir Capsules for Covid Treatment in India
MSN Laboratories said it has received its clinical trial approval from the DGCI to perform a study on Molnupiravir capsules on mild to moderate Covid patients.from Top India News- News18.com https://ift.tt/3vofFN5
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment